BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9658090)

  • 1. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus.
    Willett BJ; Adema K; Heveker N; Brelot A; Picard L; Alizon M; Turner JD; Hoxie JA; Peiper S; Neil JC; Hosie MJ
    J Virol; 1998 Aug; 72(8):6475-81. PubMed ID: 9658090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.
    Willett BJ; Picard L; Hosie MJ; Turner JD; Adema K; Clapham PR
    J Virol; 1997 Sep; 71(9):6407-15. PubMed ID: 9261358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus.
    Richardson J; Pancino G; Merat R; Leste-Lasserre T; Moraillon A; Schneider-Mergener J; Alizon M; Sonigo P; Heveker N
    J Virol; 1999 May; 73(5):3661-71. PubMed ID: 10196258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of feline immunodeficiency virus infection by stromal cell-derived factor.
    Hosie MJ; Broere N; Hesselgesser J; Turner JD; Hoxie JA; Neil JC; Willett BJ
    J Virol; 1998 Mar; 72(3):2097-104. PubMed ID: 9499065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus.
    Willett BJ; Cannon CA; Hosie MJ
    J Virol; 2002 Sep; 76(18):9242-52. PubMed ID: 12186908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication.
    de Parseval A; Ngo S; Sun P; Elder JH
    J Virol; 2004 Sep; 78(17):9132-43. PubMed ID: 15308709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.
    de Parseval A; Elder JH
    J Virol; 2001 May; 75(10):4528-39. PubMed ID: 11312323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of the V3 domain in the surface subunit of the feline immunodeficiency virus envelope glycoprotein with the equivalent region of a T cell-tropic human immunodeficiency virus type 1 results in a chimeric surface protein that efficiently binds to CXCR4.
    González SA; Falcón JI; Affranchino JL
    AIDS Res Hum Retroviruses; 2014 Mar; 30(3):250-9. PubMed ID: 24148007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.
    Johnston JB; Power C
    J Virol; 2002 Apr; 76(8):3626-36. PubMed ID: 11907202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells.
    Poeschla EM; Looney DJ
    J Virol; 1998 Aug; 72(8):6858-66. PubMed ID: 9658135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
    Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
    J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.
    Sundstrom M; White RL; de Parseval A; Sastry KJ; Morris G; Grant CK; Elder JH
    J Virol; 2008 Sep; 82(18):9134-42. PubMed ID: 18596086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of feline immunodeficiency virus envelope glycoprotein-mediated fusion.
    Garg H; Fuller FJ; Tompkins WA
    Virology; 2004 Apr; 321(2):274-86. PubMed ID: 15051387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains.
    Lu Z; Berson JF; Chen Y; Turner JD; Zhang T; Sharron M; Jenks MH; Wang Z; Kim J; Rucker J; Hoxie JA; Peiper SC; Doms RW
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6426-31. PubMed ID: 9177234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feline immunodeficiency virus envelope glycoprotein mediates apoptosis in activated PBMC by a mechanism dependent on gp41 function.
    Garg H; Joshi A; Tompkins WA
    Virology; 2004 Dec; 330(2):424-36. PubMed ID: 15567436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.
    Hu QY; Fink E; Happer M; Elder JH
    J Virol; 2011 Jul; 85(14):7108-17. PubMed ID: 21543468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus.
    de Parseval A; Chatterji U; Morris G; Sun P; Olson AJ; Elder JH
    Nat Struct Mol Biol; 2005 Jan; 12(1):60-6. PubMed ID: 15592478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
    Medinas RJ; Lambert DM; Tompkins WA
    J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses.
    Brelot A; Heveker N; Adema K; Hosie MJ; Willett B; Alizon M
    J Virol; 1999 Apr; 73(4):2576-86. PubMed ID: 10074102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
    Chabot DJ; Zhang PF; Quinnan GV; Broder CC
    J Virol; 1999 Aug; 73(8):6598-609. PubMed ID: 10400757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.